Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.
Identifieur interne : 000418 ( Ncbi/Curation ); précédent : 000417; suivant : 000419Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.
Auteurs : F. Durif [France] ; B. Debilly ; M. Galitzky ; D. Morand ; F. Viallet ; M. Borg ; S. Thobois ; E. Broussolle ; O. RascolSource :
- Neurology [ 1526-632X ] ; 2004.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Clozapine (therapeutic use), Double-Blind Method, Dyskinesia, Drug-Induced (drug therapy), Dyskinesia, Drug-Induced (etiology), Humans, Levodopa (adverse effects), Levodopa (therapeutic use), Middle Aged, Parkinson Disease (complications), Parkinson Disease (drug therapy), Serotonin Receptor Agonists (therapeutic use), Treatment Outcome.
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Clozapine, Levodopa, Serotonin Receptor Agonists.
- complications : Parkinson Disease.
- drug therapy : Dyskinesia, Drug-Induced, Parkinson Disease.
- etiology : Dyskinesia, Drug-Induced.
- Aged, Double-Blind Method, Humans, Middle Aged, Treatment Outcome.
Abstract
To investigate the efficacy and safety of clozapine in the treatment of levodopa-induced dyskinesias (LID) in patients with severe Parkinson disease (PD).
PubMed: 14872017
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001037
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000F96
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000F96
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000418
Links to Exploration step
pubmed:14872017Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.</title><author><name sortKey="Durif, F" sort="Durif, F" uniqKey="Durif F" first="F" last="Durif">F. Durif</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Hôpital Gabriel Montpied, Clermont-Ferrand, France. fdurif@chu-clermontferrand.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Neurology, Hôpital Gabriel Montpied, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Debilly, B" sort="Debilly, B" uniqKey="Debilly B" first="B" last="Debilly">B. Debilly</name></author><author><name sortKey="Galitzky, M" sort="Galitzky, M" uniqKey="Galitzky M" first="M" last="Galitzky">M. Galitzky</name></author><author><name sortKey="Morand, D" sort="Morand, D" uniqKey="Morand D" first="D" last="Morand">D. Morand</name></author><author><name sortKey="Viallet, F" sort="Viallet, F" uniqKey="Viallet F" first="F" last="Viallet">F. Viallet</name></author><author><name sortKey="Borg, M" sort="Borg, M" uniqKey="Borg M" first="M" last="Borg">M. Borg</name></author><author><name sortKey="Thobois, S" sort="Thobois, S" uniqKey="Thobois S" first="S" last="Thobois">S. Thobois</name></author><author><name sortKey="Broussolle, E" sort="Broussolle, E" uniqKey="Broussolle E" first="E" last="Broussolle">E. Broussolle</name></author><author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:14872017</idno><idno type="pmid">14872017</idno><idno type="wicri:Area/PubMed/Corpus">001037</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001037</idno><idno type="wicri:Area/PubMed/Curation">000F96</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F96</idno><idno type="wicri:Area/PubMed/Checkpoint">000F96</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F96</idno><idno type="wicri:Area/Ncbi/Merge">000418</idno><idno type="wicri:Area/Ncbi/Curation">000418</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.</title><author><name sortKey="Durif, F" sort="Durif, F" uniqKey="Durif F" first="F" last="Durif">F. Durif</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Hôpital Gabriel Montpied, Clermont-Ferrand, France. fdurif@chu-clermontferrand.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Neurology, Hôpital Gabriel Montpied, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Debilly, B" sort="Debilly, B" uniqKey="Debilly B" first="B" last="Debilly">B. Debilly</name></author><author><name sortKey="Galitzky, M" sort="Galitzky, M" uniqKey="Galitzky M" first="M" last="Galitzky">M. Galitzky</name></author><author><name sortKey="Morand, D" sort="Morand, D" uniqKey="Morand D" first="D" last="Morand">D. Morand</name></author><author><name sortKey="Viallet, F" sort="Viallet, F" uniqKey="Viallet F" first="F" last="Viallet">F. Viallet</name></author><author><name sortKey="Borg, M" sort="Borg, M" uniqKey="Borg M" first="M" last="Borg">M. Borg</name></author><author><name sortKey="Thobois, S" sort="Thobois, S" uniqKey="Thobois S" first="S" last="Thobois">S. Thobois</name></author><author><name sortKey="Broussolle, E" sort="Broussolle, E" uniqKey="Broussolle E" first="E" last="Broussolle">E. Broussolle</name></author><author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name></author></analytic><series><title level="j">Neurology</title><idno type="eISSN">1526-632X</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Clozapine (therapeutic use)</term><term>Double-Blind Method</term><term>Dyskinesia, Drug-Induced (drug therapy)</term><term>Dyskinesia, Drug-Induced (etiology)</term><term>Humans</term><term>Levodopa (adverse effects)</term><term>Levodopa (therapeutic use)</term><term>Middle Aged</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Serotonin Receptor Agonists (therapeutic use)</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Clozapine</term><term>Levodopa</term><term>Serotonin Receptor Agonists</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Double-Blind Method</term><term>Humans</term><term>Middle Aged</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To investigate the efficacy and safety of clozapine in the treatment of levodopa-induced dyskinesias (LID) in patients with severe Parkinson disease (PD).</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000418 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000418 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:14872017
|texte= Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:14872017" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |